Andrew Guggenhime, President and CFO at Vaxcyte, Inc. (PCVX), sold 15,497 shares at $45.89 ($711K) on 2023-10-18, disclosed to the SEC on 2023-10-20.
Scheduled sale ($711k) by President and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.89 | 7,497 | $344K | 48.4% |
| 2 | $45.89 | 7,497 | $344K | 48.4% |
| 3 | $46.32 | 503 | $23K | 3.3% |
| Total | $45.90 avg | 15,497 | $711K | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $530K | — | Filing → |
| PCVX | SELL | 2025-02-19 | $1.3M | — | Filing → |
| PCVX | SELL | 2025-01-22 | $1.4M | — | Filing → |